Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells.

Matrix metalloproteinase-9 (MMP-9) plays an important role in the invasion and metastasis of cancer cells. In this study, we examined the inhibitory effect of silibinin, a flavonoid antioxidant from milk thistle (Silybum marianum L.) on PMA-induced MMP-9 expression in MCF-7 human breast carcinoma cells. Silibinin significantly and selectively suppressed PMA-induced MMP-9 expression in MCF-7. Silibinin has been found to inhibit PMA-induced MMP-9 gene transcriptional activity by blocking the activation of AP-1 via MAPK signaling pathways. Moreover, the Matrigel invasion assay showed that silibinin reduces PMA-induced invasion of MCF-7 cells. These results suggest that silibinin represents a potential anti-metastatic agent suppressing PMA-induced cancer cell invasion through the specific inhibition of AP-1-dependent MMP-9 gene expression.

[1]  Cheorl-Ho Kim,et al.  ERK1/2 mediates TNF‐α‐induced matrix metalloproteinase‐9 expression in human vascular smooth muscle cells via the regulation of NF‐κB and AP‐1: Involvement of the ras dependent pathway , 2004, Journal of cellular physiology.

[2]  R. Agarwal,et al.  Prostate cancer prevention by silibinin. , 2004, Current cancer drug targets.

[3]  R. Agarwal,et al.  Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels. , 2002, Cancer research.

[4]  J. Pfeilschifter,et al.  Amplification of IL-1β-Induced Matrix Metalloproteinase-9 Expression by Superoxide in Rat Glomerular Mesangial Cells Is Mediated by Increased Activities of NF-κB and Activating Protein-1 and Involves Activation of the Mitogen-Activated Protein Kinase Pathways1 , 2000, The Journal of Immunology.

[5]  Junming Guo,et al.  Enhancement of mammary carcinogenesis in two rodent models by silymarin dietary supplements. , 2006, Carcinogenesis.

[6]  A. Cho,et al.  Mitogen-Activated Protein Kinases Mediate Matrix Metalloproteinase-9 Expression in Vascular Smooth Muscle Cells , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[7]  Shung-Haur Yang,et al.  Anti-angiogenic effect of silymarin on colon cancer LoVo cell line. , 2003, The Journal of surgical research.

[8]  A. Scorilas,et al.  Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negativeatients , 2001, British Journal of Cancer.

[9]  Young-Chae Chang,et al.  Ascochlorin Inhibits Matrix Metalloproteinase-9 Expression by Suppressing Activator Protein-1-mediated Gene Expression through the ERK1/2 Signaling Pathway , 2005, Journal of Biological Chemistry.

[10]  M. Crépin,et al.  FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. , 2002, Biochemical and biophysical research communications.

[11]  L. Hudson,et al.  Epidermal growth factor (EGF)‐ and scatter factor/hepatocyte growth factor (SF/HGF)‐mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)‐9 , 1998, Journal of cellular physiology.

[12]  R. Agarwal,et al.  Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells. , 2003, Anticancer research.

[13]  L. Matrisian,et al.  Changing views of the role of matrix metalloproteinases in metastasis. , 1997, Journal of the National Cancer Institute.

[14]  W. Stetler-Stevenson,et al.  Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. , 1996, Seminars in cancer biology.

[15]  R. Agarwal,et al.  Silibinin modulates UVB-induced apoptosis via mitochondrial proteins, caspases activation, and mitogen-activated protein kinase signaling in human epidermoid carcinoma A431 cells. , 2004, Biochemical and biophysical research communications.

[16]  D. Boyd,et al.  Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. , 1998, Cancer research.

[17]  L. Dwyer-Nield,et al.  Effect of silibinin on the growth and progression of primary lung tumors in mice. , 2006, Journal of the National Cancer Institute.

[18]  J. Hyun,et al.  Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. , 2005, Biochemical and biophysical research communications.

[19]  Zhonglin Xie,et al.  Differential Regulation of Matrix Metalloproteinase-2 and -9 Expression and Activity in Adult Rat Cardiac Fibroblasts in Response to Interleukin-1β* , 2004, Journal of Biological Chemistry.

[20]  Young-Chae Chang,et al.  Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  H. Sato,et al.  Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. , 1993, Oncogene.

[22]  J. Uhm,et al.  Elevated levels of M(r) 92,000 type IV collagenase during tumor growth in vivo , 1998 .

[23]  Kazuki Nabeshima,et al.  Matrix metalloproteinases in tumor invasion: Role for cell migration , 2002, Pathology international.

[24]  Cheorl-Ho Kim,et al.  Wogonin suppresses TNF-α-induced MMP-9 expression by blocking the NF-κB activation via MAPK signaling pathways in human aortic smooth muscle cells , 2006 .

[25]  G. Girolomoni,et al.  ERK1/2 Regulates Epidermal Chemokine Expression and Skin Inflammation1 , 2005, The Journal of Immunology.

[26]  E. Lengyel,et al.  Stimulation of 92-kDa Gelatinase B Promoter Activity by ras Is Mitogen-activated Protein Kinase Kinase 1-independent and Requires Multiple Transcription Factor Binding Sites Including Closely Spaced PEA3/ets and AP-1 Sequences (*) , 1996, The Journal of Biological Chemistry.

[27]  E. Wagner,et al.  AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.

[28]  H. Haller,et al.  Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. , 2000, Journal of cell science.

[29]  S. Chu,et al.  Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. , 2005, Chemico-biological interactions.

[30]  J. Woessner,et al.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.